These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12528314)

  • 21. Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease.
    Pisanu A; Lecca D; Mulas G; Wardas J; Simbula G; Spiga S; Carta AR
    Neurobiol Dis; 2014 Nov; 71():280-91. PubMed ID: 25134730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trazodone treatment protects neuronal-like cells from inflammatory insult by inhibiting NF-κB, p38 and JNK.
    Daniele S; Da Pozzo E; Zappelli E; Martini C
    Cell Signal; 2015 Aug; 27(8):1609-29. PubMed ID: 25911310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-inflammatory effects of glaucocalyxin B in microglia cells.
    Gan P; Zhang L; Chen Y; Zhang Y; Zhang F; Zhou X; Zhang X; Gao B; Zhen X; Zhang J; Zheng LT
    J Pharmacol Sci; 2015 May; 128(1):35-46. PubMed ID: 26003084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel azulenyl nitrone antioxidant protects against MPTP and 3-nitropropionic acid neurotoxicities.
    Yang L; Calingasan NY; Chen J; Ley JJ; Becker DA; Beal MF
    Exp Neurol; 2005 Jan; 191(1):86-93. PubMed ID: 15589515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroprotective effects of creatine.
    Beal MF
    Amino Acids; 2011 May; 40(5):1305-13. PubMed ID: 21448659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissection of tumor-necrosis factor-alpha inhibition of long-term potentiation (LTP) reveals a p38 mitogen-activated protein kinase-dependent mechanism which maps to early-but not late-phase LTP.
    Butler MP; O'Connor JJ; Moynagh PN
    Neuroscience; 2004; 124(2):319-26. PubMed ID: 14980382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnesium Lithospermate B Suppresses Lipopolysaccharide-Induced Neuroinflammation in BV2 Microglial Cells and Attenuates Neurodegeneration in Lipopolysaccharide-Injected Mice.
    Tai Y; Qiu Y; Bao Z
    J Mol Neurosci; 2018 Jan; 64(1):80-92. PubMed ID: 29196883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenyl N-tert-butylnitrone down-regulates interleukin-1 beta-stimulated matrix metalloproteinase-13 gene expression in human chondrocytes: suppression of c-Jun NH2-terminal kinase, p38-mitogen-activated protein kinase and activating protein-1.
    Ahmed S; Rahman A; Hasnain A; Goldberg VM; Haqqi TM
    J Pharmacol Exp Ther; 2003 Jun; 305(3):981-8. PubMed ID: 12626640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intestinal inflammation downregulates smooth muscle CPI-17 through induction of TNF-alpha and causes motility disorders.
    Ohama T; Hori M; Momotani E; Iwakura Y; Guo F; Kishi H; Kobayashi S; Ozaki H
    Am J Physiol Gastrointest Liver Physiol; 2007 May; 292(5):G1429-38. PubMed ID: 17307724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nitrone spin on cerebral ischemia.
    Doggrell SA
    Curr Opin Investig Drugs; 2006 Jan; 7(1):20-4. PubMed ID: 16425667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The protease Omi cleaves the mitogen-activated protein kinase kinase MEK1 to inhibit microglial activation.
    Hu Q; Li B; Xu R; Chen D; Mu C; Fei E; Wang G
    Sci Signal; 2012 Aug; 5(238):ra61. PubMed ID: 22912494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent clinical failures in Parkinson's disease with apoptosis inhibitors underline the need for a paradigm shift in drug discovery for neurodegenerative diseases.
    Waldmeier P; Bozyczko-Coyne D; Williams M; Vaught JL
    Biochem Pharmacol; 2006 Nov; 72(10):1197-206. PubMed ID: 16901468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroprotective and cognitive enhancing effects of a multi-targeted food intervention in an animal model of neurodegeneration and depression.
    Borre YE; Panagaki T; Koelink PJ; Morgan ME; Hendriksen H; Garssen J; Kraneveld AD; Olivier B; Oosting RS
    Neuropharmacology; 2014 Apr; 79():738-49. PubMed ID: 24286859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of Natural Compounds in Neurodegenerative Disorders.
    Srivastava P; Yadav RS
    Adv Neurobiol; 2016; 12():107-23. PubMed ID: 27651251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Curcumin confers neuroprotection against alcohol-induced hippocampal neurodegeneration via CREB-BDNF pathway in rats.
    Motaghinejad M; Motevalian M; Fatima S; Hashemi H; Gholami M
    Biomed Pharmacother; 2017 Mar; 87():721-740. PubMed ID: 28095363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroprotection in progressive brain disorders.
    Djaldetti R; Lev N; Melamed E
    Isr Med Assoc J; 2003 Aug; 5(8):576-80. PubMed ID: 12929297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Creatine for neuroprotection in neurodegenerative disease: end of story?
    Bender A; Klopstock T
    Amino Acids; 2016 Aug; 48(8):1929-40. PubMed ID: 26748651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic strategies for the treatment of stroke.
    Green AR; Shuaib A
    Drug Discov Today; 2006 Aug; 11(15-16):681-93. PubMed ID: 16846795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Curcumin in Regulation of TNF-α Mediated Brain Inflammatory Responses.
    Baj T; Seth R
    Recent Pat Inflamm Allergy Drug Discov; 2018; 12(1):69-77. PubMed ID: 29972106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: Methylene blue connects the dots.
    Yang SH; Li W; Sumien N; Forster M; Simpkins JW; Liu R
    Prog Neurobiol; 2017 Oct; 157():273-291. PubMed ID: 26603930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.